Global Drugs for Malaria Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Drugs for Malaria

• 1.1 Definition of Drugs for Malaria
• 1.2 Drugs for Malaria Segment by Type
  • 1.2.1 Global Drugs for Malaria Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Aryl Aminoalcohol Compounds
  • 1.2.3 Antifolate Compounds
  • 1.2.4 Artemisinin Compounds
• 1.3 Drugs for Malaria Segment by Applications
  • 1.3.1 Global Drugs for Malaria Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Prevention
  • 1.3.3 Treatment
  • 1.3.4 Other
• 1.4 Global Drugs for Malaria Overall Market
  • 1.4.1 Global Drugs for Malaria Revenue (2014-2025)
  • 1.4.2 Global Drugs for Malaria Production (2014-2025)
  • 1.4.3 North America Drugs for Malaria Status and Prospect (2014-2025)
  • 1.4.4 Europe Drugs for Malaria Status and Prospect (2014-2025)
  • 1.4.5 China Drugs for Malaria Status and Prospect (2014-2025)
  • 1.4.6 Japan Drugs for Malaria Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Drugs for Malaria Status and Prospect (2014-2025)
  • 1.4.8 India Drugs for Malaria Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Drugs for Malaria
• 2.3 Manufacturing Process Analysis of Drugs for Malaria
• 2.4 Industry Chain Structure of Drugs for Malaria

3 Development and Manufacturing Plants Analysis of Drugs for Malaria

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Drugs for Malaria Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Drugs for Malaria
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Drugs for Malaria Production and Capacity Analysis
• 4.2 Drugs for Malaria Revenue Analysis
• 4.3 Drugs for Malaria Price Analysis
• 4.4 Market Concentration Degree

5 Drugs for Malaria Regional Market Analysis

• 5.1 Drugs for Malaria Production by Regions
  • 5.1.1 Global Drugs for Malaria Production by Regions
  • 5.1.2 Global Drugs for Malaria Revenue by Regions
• 5.2 Drugs for Malaria Consumption by Regions
• 5.3 North America Drugs for Malaria Market Analysis
  • 5.3.1 North America Drugs for Malaria Production
  • 5.3.2 North America Drugs for Malaria Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Drugs for Malaria Import and Export
• 5.4 Europe Drugs for Malaria Market Analysis
  • 5.4.1 Europe Drugs for Malaria Production
  • 5.4.2 Europe Drugs for Malaria Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Drugs for Malaria Import and Export
• 5.5 China Drugs for Malaria Market Analysis
  • 5.5.1 China Drugs for Malaria Production
  • 5.5.2 China Drugs for Malaria Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Drugs for Malaria Import and Export
• 5.6 Japan Drugs for Malaria Market Analysis
  • 5.6.1 Japan Drugs for Malaria Production
  • 5.6.2 Japan Drugs for Malaria Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Drugs for Malaria Import and Export
• 5.7 Southeast Asia Drugs for Malaria Market Analysis
  • 5.7.1 Southeast Asia Drugs for Malaria Production
  • 5.7.2 Southeast Asia Drugs for Malaria Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Drugs for Malaria Import and Export
• 5.8 India Drugs for Malaria Market Analysis
  • 5.8.1 India Drugs for Malaria Production
  • 5.8.2 India Drugs for Malaria Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Drugs for Malaria Import and Export

6 Drugs for Malaria Segment Market Analysis (by Type)

• 6.1 Global Drugs for Malaria Production by Type
• 6.2 Global Drugs for Malaria Revenue by Type
• 6.3 Drugs for Malaria Price by Type

7 Drugs for Malaria Segment Market Analysis (by Application)

• 7.1 Global Drugs for Malaria Consumption by Application
• 7.2 Global Drugs for Malaria Consumption Market Share by Application (2014-2019)

8 Drugs for Malaria Major Manufacturers Analysis

• 8.1 Cipla
  • 8.1.1 Cipla Drugs for Malaria Production Sites and Area Served
  • 8.1.2 Cipla Product Introduction, Application and Specification
  • 8.1.3 Cipla Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Guilin Pharmaceutical
  • 8.2.1 Guilin Pharmaceutical Drugs for Malaria Production Sites and Area Served
  • 8.2.2 Guilin Pharmaceutical Product Introduction, Application and Specification
  • 8.2.3 Guilin Pharmaceutical Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 IPCA Laboratories
  • 8.3.1 IPCA Laboratories Drugs for Malaria Production Sites and Area Served
  • 8.3.2 IPCA Laboratories Product Introduction, Application and Specification
  • 8.3.3 IPCA Laboratories Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 GlaxoSmithKline
  • 8.4.1 GlaxoSmithKline Drugs for Malaria Production Sites and Area Served
  • 8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.4.3 GlaxoSmithKline Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Mylan Labs
  • 8.5.1 Mylan Labs Drugs for Malaria Production Sites and Area Served
  • 8.5.2 Mylan Labs Product Introduction, Application and Specification
  • 8.5.3 Mylan Labs Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Roche
  • 8.6.1 Roche Drugs for Malaria Production Sites and Area Served
  • 8.6.2 Roche Product Introduction, Application and Specification
  • 8.6.3 Roche Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Novartis
  • 8.7.1 Novartis Drugs for Malaria Production Sites and Area Served
  • 8.7.2 Novartis Product Introduction, Application and Specification
  • 8.7.3 Novartis Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Sanofi Aventis
  • 8.8.1 Sanofi Aventis Drugs for Malaria Production Sites and Area Served
  • 8.8.2 Sanofi Aventis Product Introduction, Application and Specification
  • 8.8.3 Sanofi Aventis Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Ajanta Pharma
  • 8.9.1 Ajanta Pharma Drugs for Malaria Production Sites and Area Served
  • 8.9.2 Ajanta Pharma Product Introduction, Application and Specification
  • 8.9.3 Ajanta Pharma Drugs for Malaria Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Drugs for Malaria Market

• 9.1 Global Drugs for Malaria Market Trend Analysis
  • 9.1.1 Global Drugs for Malaria Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Drugs for Malaria Regional Market Trend
  • 9.2.1 North America Drugs for Malaria Forecast 2019-2025
  • 9.2.2 Europe Drugs for Malaria Forecast 2019-2025
  • 9.2.3 China Drugs for Malaria Forecast 2019-2025
  • 9.2.4 Japan Drugs for Malaria Forecast 2019-2025
  • 9.2.5 Southeast Asia Drugs for Malaria Forecast 2019-2025
  • 9.2.6 India Drugs for Malaria Forecast 2019-2025
• 9.3 Drugs for Malaria Market Trend (Product Type)
• 9.4 Drugs for Malaria Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Drugs for Malaria Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List